Objective: To evaluate the effect of Yinchen Wulin powder in treating hyperlipidemia. Method: Randomized control trials for studying the effect of Yinchen Wulin powder in treating hyperlipidemia from January 2000 to January 2013 were retrieved from the Cochrane library

Pubmed

CNKI

Wanfang and VIP database. The inclusion and exclusion standards were followed in screening literatures

extracting materials and evaluating their quality. The study results of the included literatures were analyzed by RevMan 5.2. Result: Totally 10 RCTs were included and involved 711 patients. According to the the results of the Meta-analysis

compared with the control group

the total effective rate of the treatment group increased. In decreasing the cholesterol (TC)

Yinchen Wulin powder was similar to statins and betts and superior to other Chinese patent lipid lowering medicines or other intervention factors. In decreasing the triglyceride (TG)

Yinchen Wulin powder was superior to statins and other factors and was similar to betts. In increasing the high density lipoprotein (HDL)

Yinchen Wulin powder was superior to betts and other factors

and similar to Statins. In decreasing the low density lipoprotein (LDL)

Yinchen Wulin powder was superior to betts and other factors

and only next to Statins. Conclusion: Yinchen Wulin powder has a better efficiency in treating hyperlipidemia.